Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease. [electronic resource]

By: Contributor(s): Producer: 19961112Description: 673-83 p. digitalISSN:
  • 0269-2813
Subject(s): Online resources: In: Alimentary pharmacology & therapeutics vol. 9
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.